TABLE 2.

Anticoagulation control.

Clinical Variables	Mean ± SD
INR values in therapeutic range	59.39% ± 32.84
Duration of therapy upon recruitment
0–6 wk	35.30% ± 23.28
>6 wk	60.31% ± 32.83
Indication
VTE	54.13% ± 30.87
DVT	55.95% ± 32.32
PE	50.56% ± 29.07
AF	62.65% ± 32.31
Stroke	57.36% ± 39.73
Age
16–45 yr	56.24% ± 34.59
46–65 yr	60.55% ± 30.79
≥65 yr	60.09% ± 34
Time INR was within therapeutic range(TTR) (Overall)	57.81% ± 32.08
Duration of therapy upon recruitment
0–6 wk	38.30% ± 27.83
>6 wk	57.98% ± 32.34
Indication
VTE	49.71% ± 29.38
DVT	52.04% ± 31.03
PE	46.21% ± 26.75
A. Fib	62.19% ± 32.29
Ischemic stroke	54.27% ± 37.33
Age
16–45 yr	52.44% ± 32.76
46–65 yr	58.13% ± 30.04
>65 yr	59.27% ± 34.39
INR Target
2–3	59.2 ± 33.02%
2.5–3.5	77.83% ± 17.82